What is the comprehensive health history of a 65-year-old male, 6 feet tall, weighing 204 pounds, with a history of Hyperlipidemia (HLD), Benign Prostatic Hyperplasia (BPH) managed with tamsulosin (Flomax), taking aspirin (acetylsalicylic acid) and a statin, and experiencing insomnia requiring sleeping pills, who is overweight and experiences stress and sleep disturbances due to his job as a professor?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Mr. Smith is a 65-year-old male who presents for a comprehensive health assessment, and based on the provided information, his health history and current management plan should be prioritized to address his benign prostatic hyperplasia (BPH), hyperlipidemia, overweight, sleep disturbance, and work-related stress.

Subjective:

Mr. Smith is a 65-year-old male who presents for a comprehensive health assessment. He is 6 feet tall, weighs 204 pounds (BMI 27.7, overweight). He works as a college professor for 30 years and plans to retire next year. He lives with his 64-year-old wife, who works as a researcher, and his 20-year-old son who attends college. His medical history includes benign prostatic hyperplasia (BPH) and hyperlipidemia (HLD). Current medications include tamsulosin daily for BPH, daily baby aspirin, a statin for hyperlipidemia, and an unspecified sleeping pill as needed. He reports work-related stress and occasional sleep difficulties. For exercise, he hikes twice weekly and visits the gym twice weekly. He identifies as Catholic and attends church weekly.

Objective:

Vital signs within normal limits. Patient is alert and oriented. No physical examination performed during this visit.

Assessment:

  1. Benign Prostatic Hyperplasia - currently managed with tamsulosin, appears stable, as supported by the AUA guideline on management of BPH 1.
  2. Hyperlipidemia - managed with statin therapy, which is in line with recommendations for managing high-risk lipid abnormalities in adults 1.
  3. Overweight - BMI 27.7, which is a concern and should be addressed through dietary modifications and increased physical activity.
  4. Sleep disturbance requiring medication, which may be improved through sleep hygiene practices and non-pharmacological approaches.
  5. Work-related stress, which may be managed through stress management techniques, especially as he transitions toward retirement.
  6. Preventative health maintenance - taking aspirin for cardiovascular protection, which is a common practice for individuals with increased risk of cardiovascular disease.

Plan:

  1. Continue tamsulosin for BPH; monitor for urinary symptoms, as recommended by the AUA guideline on management of BPH 1.
  2. Continue statin therapy; order lipid panel to assess efficacy, following the guidelines for managing high-risk lipid abnormalities in adults 1.
  3. Continue aspirin therapy for cardiovascular protection, considering his risk factors for cardiovascular disease.
  4. Discuss sleep hygiene practices and consider non-pharmacological approaches to improve sleep quality before relying on sleeping pills.
  5. Recommend stress management techniques as he transitions toward retirement.
  6. Encourage continued physical activity and suggest dietary modifications to address weight concerns.
  7. Schedule routine age-appropriate cancer screenings including colonoscopy if not done within past 10 years.
  8. Recommend pneumococcal and annual influenza vaccinations.
  9. Follow up in 3 months to reassess medication efficacy and address any new concerns, ensuring that his health status is regularly monitored and managed appropriately.

From the FDA Drug Label

The FDA drug label does not answer the question.

From the Research

Subjective

  • The patient is a 65-year-old male, 6 feet tall, and weighs 204 pounds.
  • He works as a professor at a college and will be retiring next year.
  • He lives with his wife, who is 64 years old and works as a researcher, and their 20-year-old son, who is in college.
  • The patient takes tamsulosin daily for his benign prostatic hyperplasia (BPH), baby aspirin, and statin, and uses sleeping pills as needed.
  • He has a history of hyperlipidemia (HLD) and is overweight.
  • The patient is Catholic and attends church every week.
  • His work sometimes causes him stress and lack of sleep.
  • He engages in physical activities such as hiking (2 times/week) and going to the gym (2 times/week).

Objective

  • The patient's medication regimen includes tamsulosin, which has been shown to be effective in improving symptoms of BPH, as demonstrated in studies such as 2 and 3.
  • The patient's use of tamsulosin may be associated with a risk of severe hypotension, particularly during the first eight weeks of treatment or after restarting treatment, as reported in study 4.
  • The patient's history of HLD and overweight status may increase his risk of developing other health problems, such as cardiovascular disease.

Assessment

  • The patient's BPH symptoms are being managed with tamsulosin, which has been shown to be effective in improving symptoms and quality of life, as reported in studies such as 2, 3, and 5.
  • The patient's lifestyle, including his physical activity and stress levels, may be contributing to his overall health and well-being.
  • The patient's medication regimen and medical history should be monitored and managed to minimize the risk of adverse effects and optimize his overall health.

Plan

  • Continue to monitor the patient's BPH symptoms and adjust his medication regimen as needed.
  • Encourage the patient to maintain a healthy lifestyle, including regular physical activity and stress management techniques.
  • Educate the patient about the potential risks and benefits of his medication regimen, including the risk of severe hypotension associated with tamsulosin, as reported in study 4.
  • Consider referring the patient to a specialist, such as a urologist, for further evaluation and management of his BPH symptoms, as recommended in study 6.

Related Questions

What is the next appropriate step in managing a 65-year-old man with acute epididymitis, presenting with scrotal pain and swelling, increased urinary output, and trace hematuria, who has a history of benign prostatic hyperplasia (BPH) managed with tamsulosin (flomax), after restarting tamsulosin?
What are the next steps in managing a 74-year-old male patient with Benign Prostatic Hyperplasia (BPH) and moderate Bladder Outlet Obstruction (BOO), who is currently stable on tamsulosin (Flomax) 0.4 mg daily, with occasional left flank pain and a history of Hypertension (HTN)?
What to do for a 50-year-old male with benign prostatic hyperplasia (BPH) who developed urinary frequency after being treated with tamsulosin (flomax) for urinary retention?
What is the clinical significance of a 65-year-old male's elevated Prostate-Specific Antigen (PSA) level of 5.0, with a history of high-grade bladder Transitional Cell Carcinoma (TCC), Benign Prostatic Hyperplasia (BPH), and recent Computed Tomography (CT) scan showing prostatomegaly with bladder outlet obstruction?
What is the preferred treatment for Benign Prostatic Hyperplasia (BPH): MYRBETRIQ (Mirabegron) and ALFUZOSIN (Alfuzosin) or Tamsulosin (Flomax) and Dutasteride?
What is the diagnosis for a simple fracture in the distal metadiaphysis of the left radius with narrowed radiocarpal joint space?
Should a patient be treated if a urine culture and sensitivity (C&S) test grows less than 10,000 colony-forming units (CFU) per milliliter of different bacteria?
Should a patient with a chronic T8 (thoracic 8) fracture and a T4 (thoracic 4) hemangioma consult neurosurgery?
Is there a relationship between sleep apnea and epistaxis (nosebleeds)?
When should octreotide be initiated in a patient with hypotension (low blood pressure) requiring norepinephrine, following a procedure complicated by hematemesis due to esophageal varices?
What are the implications of a patient's hyperkalemia (elevated potassium level of 5.4 mEq/L) while taking potassium citrate (10 mEq, 4 tablets daily) for kidney stone prevention?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.